Be patient and realistic about the expected results, and communicate regularly with your healthcare provider about your progress
Data from clinical trials, primarily SUSTAIN-6 (NCT01720446), have demonstrated significant reductions in major adverse cardiovascular events (MACE) compared with placebo for semaglutide, accompanied by a substantial decrease in nonfatal stroke
"Glucagon regulation of energy expenditure." International Journal of Molecular Sciences
In HF, the inadequate supply of oxygen causes the heart to take up and utilize glucose as a more efficient energy substrate 4
Which conditions does the table say may limit timing flexibility
However, the gastrointestinal side effects, including diarrhea, can sometimes be a barrier to long-term use